|
 |
Clindamycin PhosphateThis page contains recent news articles, when available, and an overview of Clindamycin Phosphate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Clindamycin Phosphate (when available) Clindamycin is an antibiotic, similar to and a derivative of lincomycin. Clindamycin can be used in topical or systemic treatment. It is effective as an anti-anaerobic antibiotic and antiprotozoal. For the treatment of serious infections caused by susceptible anaerobic bacteria (anaerobes, streptococci, pneumococci, and staphylococci) Mechanism Of Action: Systemic/Vaginal-Clindamycin inhibits protein synthesis of bacteria by binding to the 50 S ribosomal subunits of the bacteria. Topical-Clindamycin reduces free fatty acid concentrations on the skin and to suppress the growth of Propionibacterium acnes (Corynebacterium acnes) , an anaerobe found in sebaceous glands and follicles. News Articles on Clindamycin Medicis Reports Second Quarter 2009 Financial Results - Aug 5, 2009 ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, AMMONUL(R) (sodium phenylacetate and sodium benzoate) Injection 10%/10%, BUPHENYL(R) FOXBusiness Transconjunctival Orbital Invasion by Methicillin-Resistant ... - 13 Jul 2009 Culture of the drainage grew MRSA susceptible to vancomycin hydrochloride, rifampin, and clindamycin phosphate but resistant to penicillin and cefazolin Archives of Ophthalmology Medicis Announces New Notice of Allowance for SOLODYN(R) 90mg - Apr 17, 2009 TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, ZIANA(R) (clindamycin phosphate 1.2% and tretinoin GlobeNewsWire (press release) Michigan business news briefs: MGM loses $1.15 billion - 18 Mar 2009 Allegan-based Perrigo Co. has announced that its partner Cobrek Pharmaceuticals Inc. has filed an abbreviated new drug application for Clindamycin Phosphate Detroit Free Press Perrigo and Partner Cobrek Confirms Filing for Generic Version of ... - Mar 17, 2009 Evoclin(R) (clindamycin phosphate) Foam 1% is a topical antibiotic indicated for topical application in the treatment of acne vulgaris, and had sales of PR Newswire (press release) Patient-Reported Outcomes Favourable With Clindamycin Phosphate ... - Mar 11, 2009 By Jill Stein SAN FRANCISCO -- March 11, 2009 -- An assessment of patient-reported outcomes with clindamycin phosphate plus low-concentration benzoyl DG News Market Report -- In Play () - Mar 17, 2009 On The Wires Perrigo (PRGO) announces that its partner Cobrek Pharmaceuticals has filed an Abbreviated New Drug Application for Clindamycin Phosphate Foam MSN Money Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne ... - Mar 6, 2009 Acanya Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) is indicated for the topical treatment of acne vulgaris in patients 12 years of age or PR Newswire (press release) New therapies for acne offer choices - Mar 11, 2009 Acanya contains clindamycin phosphate and benzoyl peroxide. Dill said current recommendations urge limiting the use of oral antibiotics for acne management, Pediatric SuperSite Coria Laboratories Announces Acanya(TM) Gel Data Presentations at ... - Feb 26, 2009 The presentations demonstrate the efficacy and safety of once daily Acanya Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) in treating patients PR Newswire (press release) Pfizer’s TM Suit Not Entertained: Lack Of Territorial Jurisdiction. - Mar 9, 2009 ...compositions Clindamycin hydrochloride and Clindamycin phosphate under the mark 'Dalcinex', in capsule as well as injections form, just as Pfizer did. Mondaq News Alerts (registration) Medicis Announces 2008 Fourth Quarter and Year-End Conference Call ... - Feb 23, 2009 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) MSNBC Coria Laboratories announces launch of Acanya Gel - Mar 9, 2009 ...declared on 6 March the commercial launch of Acanya Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%), which is indicated for the once-daily Trading Markets (press release) Cobrekæ??交Clindamycin Phosphateå¦å??è?¯ä¸Šå¸‚申请 - Mar 17, 2009 Perrigo (PRGO)宣布，å?ˆä½œå¤¥ä¼´Cobrek Pharmaceuticalså?‘FDAæ??交Clindamycin Phosphate Foam 1%å¦å??è?¯ä¸Šå¸‚申请。 å…?è´£å£°æ˜Žï¼šæœ¬æ–‡ä»…ä»£è¡¨ä½œè€…ä¸ªäººè§‚ç‚¹ï¼Œä¸Žå‡¤å‡°ç½‘æ— å…³ã€‚ 凤凰网 Medicis to Present At JP Morgan Healthcare Conference - Jan 8, 2009 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, MSNBC Medicis Declares Cash Dividend - Dec 17, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, MarketWatch Valeant continues derma buyout streak - Dec 15, 2008 The buyout hands Valeant the newly-approved treatment for mild-to-moderate acne, Acanya (clindamycin phosphate 1.2% and benzoyl peroxide), which is expected Scrip World Pharmaceutical News (subscription), Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million - Dec 10, 2008 On October 23, 2008 , the Food and Drug Administration approved the Dow NDA for a combination product, Acanya(TM) Gel (clindamycin phosphate 1.2% and SYS-CON Media, Medicis and IMPAX Announce R&D Collaboration and Settlement - Dec 1, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, MarketWatch 美国FDA批准Arcutis Pharmaå…¬å?¸çš„Acany - Dec 1, 2008 ...一家ç§?立的专业皮肤科产å“?ç ”ç©¶æœºæž„Arcutis 制è?¯å…¬å?¸äºŽ2008å¹´11月24日对外宣布，美国FDA 已批准其1.2%å…‹æž—éœ‰ç´ ç£·é…¸é…¯+2.5%过氧化苯甲酰å¤?æ–¹å‡?胶（clindamycin phosphate 生物谷, FDA Approvals: Premarin, Norditropin, Acanya - Nov 20, 2008 On October 23, the FDA approved clindamycin phosphate 1.2% and benzoyl peroxide 2.5% gel (Acanya; Dow Pharmaceutical Sciences, Inc) for the treatment of Medscape Arcutis Pharmaceuticals Announces FDA Approval of Acanyaâ„¢ Gel for ... - Nov 20, 2008 ...of Acanya â„¢ Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) for the once-daily treatment of acne vulgaris in patients 12 years and older. Business Wire (press release), Medicis Announces Third Quarter 2008 Conference Call and Webcast - Nov 6, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, MarketWatch Medicis Announces FDA Approval of PMA Supplement for RESTYLANE - Oct 10, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) Trading Markets (press release), Medicis Announces Intent to Restate Financial Statements - Sep 24, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) GlobeNewsWire (press release), Medicis to Present At Thomas Weisel Partners Healthcare Conference ... - Sep 2, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) GlobeNewsWire (press release), Stiefel Laboratories Completes Acquisition of Barrier Therapeutics - 07 Aug 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, MarketWatch Medicis Reports Second Quarter 2008 Financial Results - Aug 5, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) MarketWatch Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott ... - Jul 29, 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, MarketWatch Medicis Announces Second Quarter 2008 Conference Call and Webcast - Jul 31, 2008 LIDEX(R) (fluocinonide) Cream 0.05%, VANOS(R) (fluocinonide) Cream 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) MarketWatch Stiefel Laboratories, Inc. Commences Tender Offer to Acquire ... - Jul 8, 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, FOXBusiness Stiefel Laboratories, Inc. Successfully Completes Tender Offer for ... - Aug 5, 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, Trading Markets (press release), Medicis to Acquire LipoSonix - Jun 16, 2008 LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, Primenewswire (press release), Medicis to Present At Goldman Sachs Global Healthcare Conference - Jun 6, 2008 LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, CNNMoney.com (press release) KV Pharmaceutical Company Reports Fiscal 2008 Results - Jun 16, 2008 ...cream prescription treatment for bacterial vaginosis (BV), Clindesse(R) (clindamycin phosphate vaginal cream 2%) in the People's Republic of China. Earthtimes (press release), Stiefel Buying Barrier Therapeutics - Jun 24, 2008 1% - benzoyl peroxide, 5%) available in the Duac® Care System (CS); Evoclin® (clindamycin phosphate) Foam, 1%; Luxiq® (betamethasone valerate) Foam, Private Equity Hub, OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday ... - Jun 23, 2008 1% - benzoyl peroxide, 5%) available in the Duac Care System (CS); Evoclin (clindamycin phosphate) Foam, 1%; Luxiq (betamethasone valerate) Foam, 0.12%; Trading Markets (press release), Medicis Announces First Quarter 2008 Conference Call and Webcast - May 6, 2008 LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, FOXBusiness Ipsen and Medicis Announce Acceptance of Reloxin(R) BLA in ... - May 18, 2008 LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, PR-Inside.com (Pressemitteilung), International Diabetes Federation Grant Supports Diabetes Self ... - May 7, 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, Trading Markets (press release), Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development - May 6, 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, Trading Markets (press release), Stiefel Laboratories Appoints First Chief Scientific Officer - Apr 7, 2008 Evoclin(R) (clindamycin phosphate) Foam, 1%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R) Cream; Olux(R) (clobetasol propionate) Foam, æ–°å?Žç¾Žé€š(æ–°é—»å?‘布), Medicis Announces the Early Adoption of Online Proxy Materials for ... - Apr 8, 2008 LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, Primenewswire (press release), DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ... - Mar 6, 2008 Some of the newest and best-known brands include Duac® Topical Gel (clindamycin, 1% - benzoyl peroxide, 5%); Evoclin® (clindamycin phosphate) Foam, 1%; CNNMoney.com Medicis Announces 2007 Fourth Quarter and Year-End Conference Call ... - Feb 26, 2008 LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, FOXBusiness Stiefel Laboratories, Inc. Appoints New President - Feb 29, 2008 Some of the newest and best- known brands include Duac(R) (clindamycin, 1% - benzoyl peroxide, 5%) Care System (CS); Evoclin(R) (clindamycin phosphate, Biloxi Sun Herald, KV Pharmaceutical Company Completes Unaudited Fiscal 2007 Results ... - Feb 15, 2008 Clindesse(R) (clindamycin phosphate vaginal cream 2%) in the People's Republic of China; -- Concluded an agreement with California-based VIVUS, MSN Money Medicis to Present At Merrill Lynch Conference - Feb 5, 2008 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, FOXBusiness Medicis to Present At 2007 Credit Suisse Annual Healthcare Conference - Nov 12, 2007 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, CNNMoney.com Stiefel Laboratories, Inc. Enters into Strategic Collaboration ... - Nov 6, 2007 Some of the newest and best-known brands include Duac(R) (clindamycin, 1% -- benzoyl peroxide, 5%) Topical Gel; Evoclin(R) (clindamycin phosphate) Foam, 1%; CNNMoney.com DUSA Expands Global Sales With Launch of Levulan(R) Kerastick(R ... - Oct 1, 2007 Some of the newest and best-known brands include Duac® Topical Gel (clindamycin, 1% - benzoyl peroxide, 5%); Evoclin® (clindamycin phosphate) Foam, 1%; CNNMoney.com Medicis to Present At Leerink Swann Aesthetics Roundtable Conference - Oct 1, 2007 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, CNNMoney.com Medicis to Present At Thomas Weisel Partners Healthcare Conference - Sep 4, 2007 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, CNNMoney.com Medicis and Hyperion Therapeutics Announce Strategic Collaboration - Aug 28, 2007 SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, and the over-the-counter brand ESOTERICA(R). CNNMoney.com Stiefel Laboratories Will Enter Into Private Equity Minority ... - Aug 9, 2007 Some of the newest and best- known brands include Duac(R) Topical Gel (clindamycin, 1% -- benzoyl peroxide, 5%); Evoclin(R) (clindamycin phosphate) Foam, CNNMoney.com Beijing Med-Pharm Hopes To Grow Quickly Through Acquisitions - Aug 23, 2007 Clindesse, or clindamycin phosphate vaginal cream, is indicated for the treatment of bacterial vaginosis in non-pregnant women. Seeking Alpha, Medicis Announces Second Quarter 2007 Conference Call and Webcast - Aug 2, 2007 CNNMoney.com0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, Medicis to Present At Wachovia Securities Nantucket Equity Conference - Jun 25, 2007 CNNMoney.com0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, FDA Sends Letter to KV Pharmaceutical About Clindesse E-Mail/Alert - May 22, 2007 PharmaLive.com (press release),The Division of Drug Marketing, Advertising, and Communications (DDMAC) has reviewed an e-Pharm/alert e-mail for Clindesse (clindamycin phosphate) Vaginal Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ... - Apr 23, 2007 PR Newswire (press release),Some of the newest and best- known brands include Duac(R) Topical Gel (clindamycin, 1% - benzoyl peroxide, 5%); Evoclin(R) (clindamycin phosphate) Foam, 1%; Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ... - Apr 23, 2007 PharmaLive.com (press release),Some of the newest and best- known brands include Duac(R) Topical Gel (clindamycin, 1% - benzoyl peroxide, 5%); Evoclin(R) (clindamycin phosphate) Foam, 1%; Medicis to Present At JPMorgan 25th Annual Healthcare Conference - Jan 4, 2007 PharmaLive.com (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, FDA Approvals: Ziana, Kadian, Polyphenon E - Dec 1, 2006 Medscape (subscription)On November 7, the FDA approved clindamycin phosphate 1.2% plus tretinoin 0.025% gel in 30- and 60-g tubes (Ziana, made by Medicis Pharmaceutical Corp) for Medicis Declares Cash Dividend - Dec 14, 2006 Primenewswire (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, European Zindaclin Licensing Agreements Restructured; Zindaclin ... - Dec 13, 2006 Earthtimes.orgZindaclin is a clindamycin phosphate 1% gel for the treatment of mild and moderate acne and was the first once-daily topical treatment launched in Europe. FDA Approves Ziana(TM) (Clindamycin Phosphate 1.2% and Tretinoin ... Nov 8, 2006 ...announced that the US Food and Drug Administration ("FDA") has approved Ziana(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. ... -DG News China punishes manufacturer of killer antibiotic Oct 16, 2006 The national drug authority banned the use of Xinfu, or clindamycin phosphate glucose, two months ago after alleging it had killed at least six people. ... -TODAYonline, China Antibiotic Maker Loses License Oct 16, 2006 At least five more deaths â€â€? including that of a 74-year-old retired teacher â€â€? were later blamed on clindamycin phosphate glucose manufactured by ... -WREX-TV, Brand Names/Synonyms: Clindamycin Phosphate is also known by the following brand names and/or synonymsChlolincocin; Cleocin; Cleocin Hcl; Cleocin Pediatric; Cleocin Phosphate; Cleocin T; Cleocin T Gel; Cleocin T Lotion; Cleocin T Topical Solution; Clinda-Derm; Clindagel; Clindamicina [Inn-Spanish]; Clindamycin; Clindamycin Hcl; Clindamycin Hydrochloride; Clindamycin Phosphate; Clindamycin [Usan:Ban:Inn]; Clindamycine [French]; Clindamycine [Inn-French]; Clindamycinum [Inn-Latin]; Clindesse; Clindets; Clinimycin; DRG-0011; Dalacin; Dalacin C; Dalacin C Flavored Granules; Dalacin C Phosphate; Dalacin T Topical Solution; Evoclin; HSDB 3037; Sobelin Drug Category: Clindamycin Phosphate is categorized under the following by the FDA: Anti-bacterial Agents; Lincomycins; ATC:D10AF01; ATC:G01AA10; ATC:J01FF01 Dosage Forms: capsules; Intramuscular solution; Intravenousparenteral solution; Topical Solution; Topical Lotion; Topical Gel; Vaginal Cream; Vaginal Ovules Absorption: #NAME? Interactions: Interactions for Clindamycin: Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, it should be used with caution in patients receiving such agents. Antagonism has been demonstrated between clindamycin and erythromycin in vitro. Because of possible clinical significance, these two drugs should not be administered concurrently. Chemical IUPAC Name: N-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl)-propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |